ENDPOINTS

Axsome's $570M loan with Blackstone; Altimmune makes its own credit deal

Plus, news about Neumora, Erasca, FibroGen, Tilt Biotherapeutics, Sangamo, Leap Therapeutics, Remedy Plan, Lexeo, Karyopharm, Tango Therapeutics and Humacyte: Axsome Therapeutics gets Blackstone’s help: The commercial-stage CNS drugmaker signed a

May 13, 2025 - 15:44
 0
Axsome's $570M loan with Blackstone; Altimmune makes its own credit deal
Plus, news about Neumora, Erasca, FibroGen, Tilt Biotherapeutics, Sangamo, Leap Therapeutics, Remedy Plan, Lexeo, Karyopharm, Tango Therapeutics and Humacyte: Axsome Therapeutics gets Blackstone’s help: The commercial-stage CNS drugmaker signed a
Read More

Tags:

Previous Article

How AI is reshaping the future of informal work in the Global South

Next Article

Apple is Reportedly Developing Smart Glasses to Rival Ray-Ban Meta Glasses

Related Posts

CRISPR Therapeutics' gene editing therapy reduces bad cholesterol and triglycerides by as much as 80%

CRISPR Therapeutics' gene editing therapy reduces bad c...

May 7, 2025  0

#EASL25: Vir’s hep B disappointment, new data on Ipsen's Iqirvo

#EASL25: Vir’s hep B disappointment, new data on Ipsen'...

May 12, 2025  0

Cedars-Sinai partners with Redesign Health to build health tech startups

Cedars-Sinai partners with Redesign Health to build hea...

May 7, 2025  0